PubMed

Expression profiling predicts outcome in breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH.

Breast Cancer Res. 2003;5(1):57-8. Epub 2002 Dec 4. No abstract available. PMID: 12559048 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression profiling to predict outcome in breast cancer: the influence of sample selection.

Gruvberger SK, Ringnér M, Edén P, Borg A, Fernö M, Peterson C, Meltzer PS.

Breast Cancer Res. 2003;5(1):23-6. Epub 2002 Oct 11.PMID: 12559041 [PubMed - indexed for MEDLINE]Related articlesFree article

Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies.

Dressman MA, Walz TM, Lavedan C, Barnes L, Buchholtz S, Kwon I, Ellis MJ, Polymeropoulos MH.

Pharmacogenomics J. 2001;1(2):135-41.PMID: 11911440 [PubMed - indexed for MEDLINE]Related articles

Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.

Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V.

Cancer Res. 2009 Aug 1;69(15):6149-57. Epub 2009 Jul 21.PMID: 19622763 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.

Niméus-Malmström E, Krogh M, Malmström P, Strand C, Fredriksson I, Karlsson P, Nordenskjöld B, Stål O, Ostberg G, Peterson C, Fernö M.

Breast Cancer Res. 2008;10(2):R34. Epub 2008 Apr 22.PMID: 18430221 [PubMed - indexed for MEDLINE]Related articlesFree article

Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.

Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT.

Clin Cancer Res. 2009 Jun 1;15(11):3654-62. Epub 2009 May 26.PMID: 19470724 [PubMed - indexed for MEDLINE]Related articles

Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer.

Ditzel HJ, Lyng MB.

Nat Clin Pract Oncol. 2008 Jul;5(7):376-7. Epub 2008 May 27. No abstract available. PMID: 18506164 [PubMed - indexed for MEDLINE]Related articles

First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.

Helms MW, Packeisen J, August C, Schittek B, Boecker W, Brandt BH, Buerger H.

J Pathol. 2005 Jul;206(3):366-76.PMID: 15892165 [PubMed - indexed for MEDLINE]Related articles

Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.

Nuyten DS, van de Vijver MJ.

Semin Radiat Oncol. 2008 Apr;18(2):105-14. Review.PMID: 18314065 [PubMed - indexed for MEDLINE]Related articles

Predicting the future of breast cancer.

Borg A, Fernö M, Peterson C.

Nat Med. 2003 Jan;9(1):16-8. No abstract available. PMID: 12514712 [PubMed - indexed for MEDLINE]Related articles

Translation, please.

Bleiweiss IJ, Raptis G.

Lancet Oncol. 2007 Dec;8(12):1044-5. No abstract available. PMID: 18054869 [PubMed - indexed for MEDLINE]Related articles

3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.

Matsumoto M, Sakamoto H, Yamaguchi Y, Seino Y, Takei H, Kurosumi M, Sasano H, Yaegashi N, Hayashi S.

Anticancer Res. 2009 Oct;29(10):3971-5.PMID: 19846938 [PubMed - indexed for MEDLINE]Related articles

Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.

Buechler S.

BMC Cancer. 2009 Jul 20;9:243.PMID: 19619298 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.

Clin Cancer Res. 2005 May 1;11(9):3315-9.PMID: 15867229 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer.

Kuderer NM, Lyman GH.

Cancer Invest. 2009 Nov;27(9):885-90. Review. No abstract available. PMID: 19832034 [PubMed - indexed for MEDLINE]Related articles

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, Cameron D, Bergh J, Nevins JR, Iggo RD.

Lancet Oncol. 2007 Dec;8(12):1071-8. Epub 2007 Nov 19.PMID: 18024211 [PubMed - indexed for MEDLINE]Related articles

Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer.

Schneider J, Ruschhaupt M, Buness A, Asslaber M, Regitnig P, Zatloukal K, Schippinger W, Ploner F, Poustka A, Sültmann H.

Int J Cancer. 2006 Dec 15;119(12):2974-9.PMID: 17019712 [PubMed - indexed for MEDLINE]Related articles

Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.

Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T, Hirano A, Sato T, Nishikawa K, Akiyama F, Sakamoto G, Kasumi F, Miki Y, Tanaka T, Tsunoda T.

Cancer Sci. 2004 Mar;95(3):218-25.PMID: 15016320 [PubMed - indexed for MEDLINE]Related articles

[Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy]

Kilic E, Milde-Langosch K, Müller V, Wirtz R, Ihnen M.

Pathologe. 2008 Nov;29 Suppl 2:347-52. German. PMID: 18810438 [PubMed - indexed for MEDLINE]Related articles

26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational research.

Lee AV, Chamness G, Oesterreich S.

Breast Cancer Res. 2004 Jan 19;6(2):E10.PMID: 14979916 [PubMed - indexed for MEDLINE]Related articlesFree article